Machine learning helps identify rheumatoid arthritis subtypes

The study shows that artificial intelligence and machine learning technologies can effectively and efficiently subtype pathology samples from patients with rheumatoid arthritis.

The role of an energy-producing enzyme in treating Parkinson’s

An enzyme called PGK1 has an unexpectedly critical role in the production of chemical energy in brain cells, according to a preclinical study led by researchers at Weill Cornell Medicine.

Cognitive behavioral therapy app improves anxiety in young adults

Researchers at Weill Cornell Medicine and NewYork-Presbyterian found that a self-guided cognitive behavioral therapy app significantly reduced anxiety in young adults struggling with mental health challenges.

Study finds potential link between DNA markers and aging

Researchers have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age. 

White Coat ceremony welcomes class of 2028

On Aug. 13, 106 first-year medical students received their short white coats, officially marking the beginning of their medical education.

Study confirms frequency of undetected responsiveness in severe brain injury

With surprising frequency, patients with severe brain injury can show clear signs of cognitive function on brain scans in response to requests to carry out complex mental work, even when they can’t move or speak.

Summer program gives undergraduates a taste of research life

The Bowers Undergraduate Research Experience is a 10-week summer program where Cornell undergraduates are paired with one of nearly 40 faculty mentors and their doctoral students to tackle a specific research project.

General anesthetic may lead to new epilepsy treatments

Propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders, according to a new study.

Study finds reliable performance for wireless pacemaker

A dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new option, according to results from a multi-center international clinical trial co-led by a Weill Cornell Medicine investigator.